News
1d
MedPage Today on MSNADC-Pertuzumab Promising as New Standard in HER2-Positive Metastatic Breast CancerAs such, "the combination of T-DXd and pertuzumab may represent a new first-line standard of care for patients with ...
Pluvicto demonstrated positive results in patients with PSMA-positive metastatic hormone-sensitive prostate cancer.
A new triple-drug treatment for aggressive advanced breast cancer can cut deaths by a third, a major trial has found.
Former President Joe Biden updated reporters about his cancer treatment in Delaware on Friday after delivering remarks at a ...
Stephanie Walker was diagnosed with metastatic breast cancer (MBC) nearly a decade ago — an experience she says transformed ...
Former President Joe Biden was diagnosed with an aggressive form of prostate cancer. What does it mean in terms of prognosis ...
Cell-free DNA-based liquid biopsies showed promise for monitoring response to pancreatic cancer therapies and making ...
When cancer spreads from a primary tumor to new sites throughout the body, it undergoes changes that increase its genetic ...
15hon MSN
Cancer cell movement during metastasis is a dynamic process regulated by several different signals. However, the way cells ...
Anlotinib plus chemotherapy demonstrated similar efficacy as bevacizumab plus chemotherapy for certain patients with ...
15h
News-Medical.Net on MSNGenome doubling identified as common event in metastatic cancer evolutionWhen cancer spreads from a primary tumor to new sites throughout the body, it undergoes changes that increase its genetic ...
Adding Enhertu to Perjeta improved time without cancer growth versus standard care in advanced HER2-positive breast cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results